Article
MiR-26b reverses temozolomide resistance via targeting Wee1 in glioma cells.
Cell cycle (Georgetown, Tex.) - 18 Oct 2017
Wang Lixia, Su Jingna, Zhao Zhe, Hou Yingying, Yin Xuyuan, Zheng Nana, Zhou Xiuxia, Yan Jingzhe, Xia Jun, Wang Zhiwei
Abstract excerpt
Emerging evidence has demonstrated that microRNAs (miRNA) play a critical role in chemotherapy-induced epithelial-mesenchymal transition (EMT) in glioma. However, the underlying mechanism of chemotherapy-triggered EMT has not been fully understood. In the current study, we determined the role of miR-26b in regulation of EMT in stable temozolomide (TMZ)-resistant (TR) glioma cells, which have displayed mesenchymal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
